Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) - Akerblom, A; James, S K; Koutouzis, M (J Am Coll Cardiol, 2010)
, et al.